Protagonist Therapeutics, Inc. (PTGX)

Protagonist Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	168.54	97.25	186.73	125.74	123.67	117.36
Short-Term Investments	401.92	321.66	154.89	111.61	203.24	188.45
Cash & Short-Term Investments	570.47	418.91	341.62	237.36	326.9	305.81
Cash Growth	1.15%	22.63%	43.93%	-27.39%	6.90%	129.90%
Accounts Receivable	23.36	165	10	0.01	1.57	2.43
Other Receivables	4.61	3.49	0.33	0.04	3.77	1.4
Receivables	27.97	168.49	10.33	0.05	5.33	3.82
Prepaid Expenses	4.09	4.24	3.63	5.67	8.5	5.97
Restricted Cash	-	-	-	-	-	0.01
Total Current Assets	602.53	591.64	355.58	243.08	340.74	315.61
Property, Plant & Equipment	12.7	12.61	2.15	4.63	6.73	6.41
Long-Term Investments	102.49	140.25	-	-	-	2
Other Long-Term Assets	0.29	0.23	0.23	0.23	0.23	0.45
Total Assets	718.01	744.73	357.95	247.93	347.7	324.47
Accounts Payable	3.25	1.62	0.77	3.64	1.6	3.08
Accrued Expenses	15.24	23.62	19.26	24.54	37.31	18.42
Current Portion of Leases	2.17	0.51	1.14	2.52	2.2	1.46
Current Income Taxes Payable	-	2.69	-	-	-	-
Current Unearned Revenue	14.69	18.89	-	-	1.6	14.48
Other Current Liabilities	0.16	0.07	0.1	0.48	1.31	2.81
Total Current Liabilities	35.51	47.4	21.27	31.18	44.02	40.24
Long-Term Leases	9.11	10.36	-	1.14	3.66	4.5
Long-Term Unearned Revenue	5.38	11.68	-	-	-	-
Other Long-Term Liabilities	-	-	-	-	-	0.12
Total Liabilities	49.99	69.43	21.27	32.32	47.67	44.86
Common Stock	0	0	0	-	-	-
Additional Paid-In Capital	1,055	1,016	952.49	752.72	709.68	563.39
Retained Earnings	-386.95	-340.52	-615.71	-536.76	-409.36	-283.81
Comprehensive Income & Other	-0.02	-0.08	-0.11	-0.36	-0.3	0.03
Total Common Equity	668.02	675.3	336.68	215.61	300.02	279.61
Shareholders' Equity	668.02	675.3	336.68	215.61	300.02	279.61
Total Liabilities & Equity	718.01	744.73	357.95	247.93	347.7	324.47
Total Debt	11.28	10.87	1.14	3.66	5.86	5.96
Net Cash (Debt)	661.68	548.3	340.48	233.7	321.04	301.85
Net Cash Growth	13.21%	61.04%	45.69%	-27.21%	6.36%	160.20%
Net Cash Per Share	10.22	8.43	6.00	4.77	6.93	8.78
Filing Date Shares Outstanding	62.21	61.38	58.27	51.28	48.41	43.81
Total Common Shares Outstanding	62.11	61.04	57.71	49.34	47.84	43.75
Working Capital	567.02	544.24	334.3	211.9	296.72	275.37
Book Value Per Share	10.76	11.06	5.83	4.37	6.27	6.39
Tangible Book Value	668.02	675.3	336.68	215.61	300.02	279.61
Tangible Book Value Per Share	10.76	11.06	5.83	4.37	6.27	6.39
Machinery	8.76	7.8	6.47	5.91	5.18	4.19
Leasehold Improvements	2.92	2.42	0.96	0.91	0.88	0.75

Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q